Literature DB >> 10694220

Role of tachykinin NK2 receptors in normal and altered rectal sensitivity in rats.

M Toulouse1, A M Coelho, J Fioramonti, A Lecci, C Maggi, L Buéno.   

Abstract

Irritable bowel syndrome is characterized by visceral hyperalgesia commonly associated with stress and inflammatory processes. We investigated the role of tachykinin NK2 receptors in the ability of trinitrobenzenesulphonic acid (TNBS) and stress to enhance the sensitivity of the rat rectum to distension using a selective tachykinin NK2 receptor antagonist (MEN 11420). Rats were fitted with electrodes implanted in the striated muscles of the abdomen. Rectal distension (RD) was performed with a balloon inflated by steps of 0.4 ml from 0 to 1.6 ml. Five groups were submitted to RD performed 3 days before and after intrarectal instillation of TNBS. Fifteen minutes before RD, rats were treated with saline or MEN 11420 (5 - 100 microg kg(-1) i.v.). Two other groups, submitted to 2 h restraint or sham stress sessions were randomly treated i.v. with saline or MEN 11420 (10 - 200 microg kg(-1)) prior to RD applied 20 min later. The basal response to RD was characterized by a significant increase in the number of abdominal contractions. This response occurred with a threshold volume of 0.8 ml and was dose-dependently reduced by MEN 11420 (5 - 100 microg kg(-1) i.v.). Rectal inflammation lowered the volume of distension producing abdominal contractions to 0.4 ml (allodynia). This effect was either reduced or suppressed by MEN 11420. A similar allodynia was observed after a stress session and this effect was reduced (49%) or suppressed by MEN 11420 at 200 and 100 microg kg(-1), respectively. Tachykinin NK2 receptors are involved in rectal hypersensitivity associated with inflammation and stress. British Journal of Pharmacology (2000) 129, 193 - 199

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694220      PMCID: PMC1621135          DOI: 10.1038/sj.bjp.0703040

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Electrical spiking activity and propulsion in small intestine in fed and fasted rats.

Authors:  M Rukebusch; J Fioramonti
Journal:  Gastroenterology       Date:  1975-06       Impact factor: 22.682

2.  Stress-induced changes in intestinal transit in the rat: a model for irritable bowel syndrome.

Authors:  C L Williams; R G Villar; J M Peterson; T F Burks
Journal:  Gastroenterology       Date:  1988-03       Impact factor: 22.682

3.  Further behavioral evidence that colorectal distension is a 'noxious' visceral stimulus in rats.

Authors:  T J Ness; A Randich; G F Gebhart
Journal:  Neurosci Lett       Date:  1991-09-30       Impact factor: 3.046

4.  Assessment of central noradrenergic functioning in irritable bowel syndrome using a neuroendocrine challenge test.

Authors:  T G Dinan; S Barry; S Ahkion; A Chua; P W Keeling
Journal:  J Psychosom Res       Date:  1990       Impact factor: 3.006

Review 5.  Neuropeptides and inflammatory bowel disease.

Authors:  V E Eysselein; C C Nast
Journal:  Z Gastroenterol Verh       Date:  1991-03

6.  The in vivo effect of tachykinins on airway mast cells of the rat.

Authors:  G F Joos; R A Pauwels
Journal:  Am Rev Respir Dis       Date:  1993-10

7.  Evidence of NK1 and NK2 tachykinin receptors and their involvement in histamine release in a murine mast cell line.

Authors:  S A Krumins; C A Broomfield
Journal:  Neuropeptides       Date:  1992-02       Impact factor: 3.286

Review 8.  Immobilization and restraint effects on pain reactions in animals.

Authors:  Carlo A Porro; Giancarlo Carli
Journal:  Pain       Date:  1988-03       Impact factor: 6.961

9.  Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome.

Authors:  D A Drossman; D C McKee; R S Sandler; C M Mitchell; E M Cramer; B C Lowman; A L Burger
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

10.  Psychosensory modulation of colonic sensation in the human transverse and sigmoid colon.

Authors:  M J Ford; M Camilleri; A R Zinsmeister; R B Hanson
Journal:  Gastroenterology       Date:  1995-12       Impact factor: 22.682

View more
  12 in total

1.  Colitis decreases mechanosensitive K2P channel expression and function in mouse colon sensory neurons.

Authors:  Jun-Ho La; G F Gebhart
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-04-21       Impact factor: 4.052

2.  Footshock stress differentially affects responses of two subpopulations of spinal dorsal horn neurons to urinary bladder distension in rats.

Authors:  Meredith T Robbins; Jennifer Deberry; Alan Randich; Timothy J Ness
Journal:  Brain Res       Date:  2011-03-02       Impact factor: 3.252

Review 3.  Treatment of abdominal pain in irritable bowel syndrome.

Authors:  Tim Vanuytsel; Jan F Tack; Guy E Boeckxstaens
Journal:  J Gastroenterol       Date:  2014-05-21       Impact factor: 7.527

Review 4.  Irritable bowel syndrome: new agents targeting serotonin receptor subtypes.

Authors:  F De Ponti; M Tonini
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Tachykinin NK(2) receptors and enhancement of cholinergic transmission in the inflamed rat colon: an in vivo motility study.

Authors:  F Carini; A Lecci; M Tramontana; S Giuliani; C A Maggi
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

6.  The role of transient receptor potential vanilloid 1 in mechanical and chemical visceral hyperalgesia following experimental colitis.

Authors:  A Miranda; E Nordstrom; A Mannem; C Smith; B Banerjee; J N Sengupta
Journal:  Neuroscience       Date:  2007-08-23       Impact factor: 3.590

7.  Therapeutic advances in functional gastrointestinal disease: irritable bowel syndrome.

Authors:  Alexandru Gaman; Maria Cristina Bucur; Braden Kuo
Journal:  Therap Adv Gastroenterol       Date:  2009-05-01       Impact factor: 4.409

Review 8.  Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function.

Authors:  Pierangelo Geppetti; Marcello Trevisani
Journal:  Br J Pharmacol       Date:  2004-03-29       Impact factor: 8.739

Review 9.  Colonic smooth muscle cells and colonic motility patterns as a target for irritable bowel syndrome therapy: mechanisms of action of otilonium bromide.

Authors:  Jakub Rychter; Francisco Espín; Diana Gallego; Patri Vergara; Marcel Jiménez; Pere Clavé
Journal:  Therap Adv Gastroenterol       Date:  2014-07       Impact factor: 4.409

Review 10.  Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.

Authors:  Alessandro Lecci; Angela Capriati; Carlo Alberto Maggi
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.